Mylan&39;s Aflibercept Biosimilar Gets Green Light For Trials In India

Mylan's Aflibercept Biosimilar Gets Green Light For Trials In India

Mylan’s proposal to progress studies for its aflibercept biosimilar has been endorsed by an expert panel in India, which expects...

Original Article: Mylan's Aflibercept Biosimilar Gets Green Light For Trials In India

More From BioPortfolio on "Mylan's Aflibercept Biosimilar Gets Green Light For Trials In India"